P190BCR-ABL Chronic Myeloid Leukemia Following a Course of S-1 Plus Oxaliplatin Therapy for Advanced Gastric Adenocarcinoma

二维码有效期 120s

摘要Secondary malignant neoplasms are important late complications after chemotherapy and/or radiotherapy in cancer patients.Therapy-related malignancies include acute leukemia,myelodysplastic syndrome (MDS),lymphoma,and solid tumors.However,secondary acute lymphoid leukemia or chronic myeloid leukemia (CML) is rarely reported.[1] Here,we present a patient with P190BCR-ABL-positive CML following S-1 plus oxaliplatin therapy for gastric adenocarcinoma.The patient has given written informed consent for the use of his medical data.

作者单位 Department of Hematology, Yantai Affiliated Hospital of Binzhou Medical University, Yantai, Shandong 264100, China ^[1] Department of Hematology, Weifang People's Hospital, Weifang, Shandong 261000, China ^[2] Stem Cell Transplantation Center, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin 300020, China ^[3]

关键词 Chronic Myeloid Leukemia Gastric Cancer Oxaliplatin P190BCR-ABL S-1 Therapy-related Leukemia

栏目名称

Clinical Practice

DOI 10.4103/0366-6999.199824

发布时间 2017-03-30

基金项目

the Natural Science Foundation of Shandong Province（ZR2013HL001）； the Tianjin Application foundation and advanced technology research program（14JCZDJC33000）； China

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交